ZA200602788B - Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2H-chromen-6-YL-derivatives and drugs containing said compounds - Google Patents

Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2H-chromen-6-YL-derivatives and drugs containing said compounds

Info

Publication number
ZA200602788B
ZA200602788B ZA200602788A ZA200602788A ZA200602788B ZA 200602788 B ZA200602788 B ZA 200602788B ZA 200602788 A ZA200602788 A ZA 200602788A ZA 200602788 A ZA200602788 A ZA 200602788A ZA 200602788 B ZA200602788 B ZA 200602788B
Authority
ZA
South Africa
Prior art keywords
sulfonilamino
hidroxy
amidomethyl
chromen
dihydro
Prior art date
Application number
ZA200602788A
Inventor
Sykes David
Moloney Brian
Marrison Lester
Ziegler Dieter
Mlinaric Michael
Boecker Christiane
Brueckner Reinhard
Weske Michael
Witte Klaus
Fischer Yvan
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of ZA200602788B publication Critical patent/ZA200602788B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200602788A 2003-10-17 2004-10-14 Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2H-chromen-6-YL-derivatives and drugs containing said compounds ZA200602788B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10348298A DE10348298A1 (en) 2003-10-17 2003-10-17 Amidomethyl-substituted 2- (4-sulfonylamino) -3-hydroxy-3,4-dihydro-2H-chromen-6-ylderivade, processes and intermediates for their preparation, and medicaments containing these compounds

Publications (1)

Publication Number Publication Date
ZA200602788B true ZA200602788B (en) 2008-01-30

Family

ID=34442032

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200602788A ZA200602788B (en) 2003-10-17 2004-10-14 Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2H-chromen-6-YL-derivatives and drugs containing said compounds

Country Status (25)

Country Link
EP (1) EP1678130B1 (en)
JP (1) JP4791968B2 (en)
KR (1) KR20060129170A (en)
CN (1) CN100532375C (en)
AR (1) AR046106A1 (en)
AT (1) ATE405547T1 (en)
AU (1) AU2004281195B2 (en)
BR (1) BRPI0415523A (en)
CA (1) CA2542813C (en)
DE (3) DE10348298A1 (en)
DK (1) DK1678130T3 (en)
ES (1) ES2313126T3 (en)
HK (1) HK1096960A1 (en)
HR (1) HRP20080602T3 (en)
IL (1) IL174950A (en)
MX (1) MXPA06003958A (en)
NO (1) NO20062202L (en)
PL (1) PL1678130T3 (en)
PT (1) PT1678130E (en)
RU (1) RU2355685C2 (en)
SI (1) SI1678130T1 (en)
TW (1) TWI321564B (en)
UA (1) UA82907C2 (en)
WO (1) WO2005037780A2 (en)
ZA (1) ZA200602788B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602006016420D1 (en) * 2005-04-12 2010-10-07 Abbott Products Gmbh AMINO ALKYLAMIDOMETHYL SUBSTITUTED 2- (4-SULFONYLAMINO) -3-HYDROXY-3,4-DIHYDRO-2H-CROMEN-6-YL DERIVATIVES AND THEIR USE AS COLUMN CHANNEL BLOCKERS
US7714150B2 (en) 2005-04-12 2010-05-11 Solvay Pharmaceuticals Gmbh Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chroman-6-yl derivatives
CA2615440A1 (en) * 2005-07-22 2007-02-08 Merck & Co., Inc. Potassium channel inhibitors
GB0525164D0 (en) 2005-12-09 2006-01-18 Xention Discovery Ltd Compounds
GB0815781D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815782D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815784D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
NO3175985T3 (en) 2011-07-01 2018-04-28
US20150045305A1 (en) 2012-01-27 2015-02-12 Gilead Sciences, Inc. Combination therapies using late sodium ion channel blockers and potassium ion channel blockers
WO2014134419A1 (en) 2013-03-01 2014-09-04 Gilead Sciences, Inc. Use of ikach blockers for the treatment of cardiac diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ282172B6 (en) * 1992-11-30 1997-05-14 Smithkline Beecham Plc Benzopyran analogs process for preparing such compounds, pharmaceutical composition containing such compounds and the use thereof
DE19546736A1 (en) * 1995-12-14 1997-06-19 Hoechst Ag Substituted chromanylsulfonyl (thio) ureas, process for their preparation and their use in the manufacture of pharmaceutical preparations
CA2341678C (en) * 1998-09-01 2009-10-13 Bristol-Myers Squibb Company Potassium channel inhibitors and method
JP2000336085A (en) * 1999-03-25 2000-12-05 Nissan Chem Ind Ltd Chroman derivative
AU2830800A (en) * 1999-03-25 2000-10-16 Nissan Chemical Industries Ltd. Chroman derivatives
EP1240147A1 (en) * 1999-12-21 2002-09-18 Icagen, Inc. Potassium channel inhibitors

Also Published As

Publication number Publication date
UA82907C2 (en) 2008-05-26
IL174950A0 (en) 2006-08-20
KR20060129170A (en) 2006-12-15
AU2004281195A1 (en) 2005-04-28
JP4791968B2 (en) 2011-10-12
TW200523259A (en) 2005-07-16
CN100532375C (en) 2009-08-26
HRP20080602T3 (en) 2008-12-31
PT1678130E (en) 2008-10-08
EP1678130A2 (en) 2006-07-12
DE10348298A1 (en) 2005-05-19
BRPI0415523A (en) 2006-12-26
EP1678130B1 (en) 2008-08-20
AU2004281195B2 (en) 2010-12-16
TWI321564B (en) 2010-03-11
MXPA06003958A (en) 2006-07-05
DE502004007916D1 (en) 2008-10-02
RU2006116629A (en) 2007-11-27
SI1678130T1 (en) 2008-12-31
IL174950A (en) 2010-06-30
CA2542813A1 (en) 2005-04-28
CN1894233A (en) 2007-01-10
ES2313126T3 (en) 2009-03-01
DK1678130T3 (en) 2008-12-01
AU2004281195A2 (en) 2005-04-28
NO20062202L (en) 2006-07-03
DE112004001659D2 (en) 2006-08-10
WO2005037780A3 (en) 2007-10-18
RU2355685C2 (en) 2009-05-20
HK1096960A1 (en) 2007-06-15
JP2007516235A (en) 2007-06-21
CA2542813C (en) 2011-08-30
PL1678130T3 (en) 2009-01-30
AR046106A1 (en) 2005-11-23
ATE405547T1 (en) 2008-09-15
WO2005037780A2 (en) 2005-04-28

Similar Documents

Publication Publication Date Title
EG27104A (en) Pharmaceutical compounds
GB0315657D0 (en) Pharmaceutical compounds
GB0218625D0 (en) Pharmaceutical compounds
IL176248A0 (en) N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
IL170758A0 (en) 7-amino-isoindolyl compounds and their pharmaceutical uses
GB0217225D0 (en) Medicinal compounds
GB0204719D0 (en) Medicinal compounds
GB0220730D0 (en) Medicinal compounds
GB0324886D0 (en) Medicinal compounds
HK1096960A1 (en) Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h- chromium-6-yl-derivatives and drugs containing said compounds
GB0303396D0 (en) Medicinal compounds
GB0308511D0 (en) Pharmaceutical compounds
GB0215775D0 (en) Pharmaceutical compounds
GB0317315D0 (en) Pharmaceutical compounds
GB0328490D0 (en) Medicinal compounds
EP1484061A4 (en) Drugs containing riboflavin-type compounds
GB0313766D0 (en) Pharmaceutical compounds
GB2401043B (en) Drug
GB0301736D0 (en) Pharmaceutical compounds
GB0329617D0 (en) Pharmaceutical compounds
EP1624073A4 (en) Drug
GB0324919D0 (en) Pharmaceutical compounds
GB0329611D0 (en) Pharmaceutical compounds
GB0312509D0 (en) Pharmaceutical compounds
GB0318719D0 (en) Pharmaceutical compounds